新型头孢菌素DQ - 2556的体外活性
In vitro activity of DQ-2556, a new cephalosporin.
作者信息
Fujimoto T, Otani T, Nakajima R, Une T, Osada Y
出版信息
Antimicrob Agents Chemother. 1986 Oct;30(4):611-3. doi: 10.1128/AAC.30.4.611.
Abstract
The in vitro antibacterial activity of DQ-2556, a new semisynthetic cephalosporin, was compared with that of ceftazidime and cefotaxime. The activity of DQ-2556 against members of the family Enterobacteriaceae was roughly comparable to that of cefotaxime. Against Pseudomonas aeruginosa, DQ-2556 was slightly less active than ceftazidime. DQ-2556 was more active than the reference cephalosporins against staphylococci. Haemophilus influenzae and Neisseria gonorrhoeae were also highly susceptible to DQ-2556.
摘要
将新型半合成头孢菌素DQ - 2556的体外抗菌活性与头孢他啶和头孢噻肟进行了比较。DQ - 2556对肠杆菌科成员的活性与头孢噻肟大致相当。对于铜绿假单胞菌，DQ - 2556的活性略低于头孢他啶。DQ - 2556对葡萄球菌的活性高于参比头孢菌素。流感嗜血杆菌和淋病奈瑟菌对DQ - 2556也高度敏感。
相似文献
1
In vitro activity of DQ-2556, a new cephalosporin.新型头孢菌素DQ - 2556的体外活性
Antimicrob Agents Chemother. 1986 Oct;30(4):611-3. doi: 10.1128/AAC.30.4.611.
2
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.新型广谱头孢菌素BMY-28142的体外活性评估
Antimicrob Agents Chemother. 1985 May;27(5):679-82. doi: 10.1128/AAC.27.5.679.
3
An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.新型头孢菌素的体外比较，特别涉及铜绿假单胞菌。
J Antimicrob Chemother. 1981 Sep;8 Suppl B:97-105. doi: 10.1093/jac/8.suppl_b.97.
4
Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.头孢他啶，一种对假单胞菌有效的头孢菌素：体外抗菌活性评估，包括纸片扩散法药敏试验的建议。
J Antimicrob Chemother. 1981 Sep;8 Suppl B:187-211. doi: 10.1093/jac/8.suppl_b.187.
5
6
7
In vitro and in vivo activity of DQ-2556, a new cephalosporin.
Chemotherapy. 1995 Jan-Feb;41(1):5-13. doi: 10.1159/000239318.
8
In vitro activity of a new cephalosporin ME-1206 compared with other agents.新型头孢菌素ME-1206与其他药物的体外活性比较。
Diagn Microbiol Infect Dis. 1991 Sep-Oct;14(5):417-24. doi: 10.1016/0732-8893(91)90068-q.
9
10
GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.GR - 20263：一种对假单胞菌属和肠杆菌科具有高活性的新型氨基噻唑基头孢菌素。
Antimicrob Agents Chemother. 1980 May;17(5):807-12. doi: 10.1128/AAC.17.5.807.
引用本文的文献
1
Penetration of cefazolin, ceftriaxone, cefoperazone, and ceftazidime into human gallbladder tissue and bile.
World J Surg. 1988 Oct;12(5):641-4. doi: 10.1007/BF01655872.
2
Metabolic disposition of DQ-2556, a new cephalosporin, in rats, rabbits, dogs, and monkeys.新型头孢菌素DQ - 2556在大鼠、兔子、狗和猴子体内的代谢情况。
Antimicrob Agents Chemother. 1992 May;36(5):966-72. doi: 10.1128/AAC.36.5.966.
3
In vitro and in vivo activities of DQ-2556 and its mode of action.DQ-2556的体外和体内活性及其作用方式。
Antimicrob Agents Chemother. 1992 Dec;36(12):2595-601. doi: 10.1128/AAC.36.12.2595.
本文引用的文献
1
Method of reliable determination of minimal lethal antibiotic concentrations.可靠测定最低致死抗生素浓度的方法。
Antimicrob Agents Chemother. 1980 Nov;18(5):699-708. doi: 10.1128/AAC.18.5.699.
2
GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity.GR 20263，一种具有抗假单胞菌活性的新型广谱头孢菌素。
Antimicrob Agents Chemother. 1980 May;17(5):876-83. doi: 10.1128/AAC.17.5.876.
3
Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors.金黄色葡萄球菌对苯唑西林最低杀菌浓度的测定：技术因素的影响及意义
Antimicrob Agents Chemother. 1983 Jan;23(1):142-50. doi: 10.1128/AAC.23.1.142.
4
In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.新型广谱氨噻唑基α-甲氧基氨基头孢菌素HR810的体外评价
Antimicrob Agents Chemother. 1984 Jun;25(6):710-8. doi: 10.1128/AAC.25.6.710.
5
In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.新型广谱头孢菌素DN-9550的体外和体内活性
Antimicrob Agents Chemother. 1985 Apr;27(4):473-8. doi: 10.1128/AAC.27.4.473.
6
In vitro studies of BMY-28142, a new broad-spectrum cephalosporin.新型广谱头孢菌素BMY-28142的体外研究。
Antimicrob Agents Chemother. 1985 Feb;27(2):265-9. doi: 10.1128/AAC.27.2.265.
7
Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications.
J Infect Dis. 1985 Mar;151(3):399-406. doi: 10.1093/infdis/151.3.399.
8
HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.HR 756，一种对革兰氏阳性菌及革兰氏阴性需氧菌和厌氧菌均有活性的新型头孢菌素。
Antimicrob Agents Chemother. 1979 Feb;15(2):273-81. doi: 10.1128/AAC.15.2.273.
9
In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.新型半合成头孢菌素头孢哌酮（T-1551）的体外抗菌活性
Antimicrob Agents Chemother. 1979 Dec;16(6):731-5. doi: 10.1128/AAC.16.6.731.
Zotero 插件